Cibus, Inc.
CBUSAnalyst Consensus
Price Target Trend
Rating Trend
Recent Price Targets
| Date | Firm | Analyst | Target | Price Then | Source |
|---|---|---|---|---|---|
| Aug 23, 2024 | Canaccord Genuity | Austin Moeller | $21.00(+450%) | $3.82 | StreetInsider |
| Jul 29, 2024 | Industrial Alliance Securities | Matthew Venezia | $25.00(+407%) | $4.93 | TheFly |
| Jul 19, 2024 | Canaccord Genuity | Austin Moeller | $22.00(+358%) | $4.80 | TheFly |
Recent Rating Actions
| Firm | Action | Rating | Date |
|---|---|---|---|
| Jefferies | maintain | Hold | Mar 25, 2026 |
| Canaccord Genuity | maintain | Buy | Dec 8, 2025 |
| Canaccord Genuity | maintain | Buy | May 12, 2025 |
| HC Wainwright & Co. | maintain | Buy | Mar 21, 2025 |
| Canaccord Genuity | maintain | Buy | Jan 22, 2025 |
| HC Wainwright & Co. | maintain | Buy | Nov 11, 2024 |
| Canaccord Genuity | maintain | Buy | Oct 22, 2024 |
| Alliance Global Partners | maintain | Buy | Sep 24, 2024 |
| Canaccord Genuity | maintain | Buy | Sep 19, 2024 |
| Canaccord Genuity | maintain | Buy | Aug 12, 2024 |
| HC Wainwright & Co. | maintain | Buy | May 10, 2024 |
| HC Wainwright & Co. | maintain | Buy | Mar 22, 2024 |
Earnings History
Next report: Nov 12, 2026 · EPS est. $-0.20| Report Date | EPS Actual | EPS Est. | Revenue Actual | Revenue Est. |
|---|---|---|---|---|
| Aug 13, 2026 | $-0.29 | $-0.19 | $994.0K | $1.7M |
| May 14, 2026 | $-0.33 | $-0.35 | $1.7M | $1.6M |
| Mar 17, 2026 | $-0.42 | $-0.43 | $1.1M | $1.6M |
| Nov 13, 2025 | $-0.44 | $-0.41 | $615.0K | $1.4M |
| Aug 14, 2025 | $-0.61 | $-0.69 | $933.0K | $1.1M |
| May 8, 2025 | $-1.34 | $-0.70 | $1.0M | $1.1M |
| Mar 20, 2025 | $-0.87 | $-0.68 | $1.2M | $1.1M |
| Nov 7, 2024 | $0.06 | $-0.89 | $1.7M | $650.0K |
News
SAN DIEGO, Nov. 03, 2026 (GLOBE NEWSWIRE) -- Cibus, Inc. (Nasdaq: CBUS), a technology company that uses biology to produce sustainable ingredients and helps farmers grow more food with fewer inputs, today announced that the company will report third quarter 2026 financial results on Thursday, November 12, 2026. Cibus' management team will host a conference call and audio webcast at 4:30 p.m. ET on that day to discuss the financial results and other company updates.
Collaboration pairs Cibus' platform for improving a plant's own genes with Crystal Crop's mustard varieties and its reach across India, with the goal of putting better-performing seed in growers' hands in a fraction of the time of conventional breeding Collaboration pairs Cibus' platform for improving a plant's own genes with Crystal Crop's mustard varieties and its reach across India, with the goal of putting better-performing seed in growers' hands in a fraction of the time of conventional bre…
Cibus, Inc. (CBUS) Q2 2026 Earnings Call Transcript
Cibus (CBUS) came out with a quarterly loss of $0.29 per share versus the Zacks Consensus Estimate of a loss of $0.26. This compares to a loss of $0.61 per share a year ago.
Cibus NASDAQ: CBUS reported second-quarter 2026 revenue of $1.0 million, compared with $0.9 million a year earlier, as the agricultural biotechnology company advanced its Sustainable Ingredients program and updated the expected timing of its initial rice launch in Latin America.
Commercialization execution advances in Rice and Sustainable Ingredients United States and European Union now aligned on generally treating crops with no added foreign DNA as conventionally bred Quarterly net cash usage declined 19% sequentially and 31% year over year SAN DIEGO, Aug. 13, 2026 (GLOBE NEWSWIRE) -- Cibus, Inc. (Nasdaq: CBUS) (the "Company"), a technology company that uses biology to produce sustainable ingredients and helps farmers grow more food with fewer inputs, today announced …